sti-1492
Generic: Anti-CD38 DAR-T·Code: STI-1492
sti-1492: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Sorrento Therapeutics, Inc. (SRNE) | Phase 1 |
Get deeper analysis on sti-1492
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis